Global Propantheline Bromide Market Insights, Forecast to 2028

Propantheline bromide (INN) is an antimuscarinic agent used for the treatment of excessive sweating (hyperhidrosis), cramps or spasms of the stomach, intestines (gut) or bladder, and involuntary urination (enuresis). It can also be used to control the symptoms of irritable bowel syndrome and similar conditions. This agent can also be used for patients who experience intense GI symptoms while tapering off of TCAs
Market Analysis and Insights: Global Propantheline Bromide Market
Due to the COVID-19 pandemic, the global Propantheline Bromide market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, 7.5mg accounting for % of the Propantheline Bromide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Propantheline Bromide market size is valued at US$ million in 2021, while the US and Europe Propantheline Bromide are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Propantheline Bromide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Propantheline Bromide include Pfizer, Shire Development, Amneal Pharmaceuticals, Mylan, Endo International, Private Formulations, Novartis, Tablicaps and Watson Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Propantheline Bromide Scope and Segment
Propantheline Bromide market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Propantheline Bromide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
7.5mg
15mg
Segment by Application
Hospital
Drug Store
By Company
Pfizer
Shire Development
Amneal Pharmaceuticals
Mylan
Endo International
Private Formulations
Novartis
Tablicaps
Watson Laboratories
Sun Pharmaceutical
Arrow Pharmaceuticals
Aspen Pharmacare
Kyowa Hakko Kirin
Chin Teng Pharmaceutical
Hikma Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE